RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
NCEs, new patented formulations and products
Respiratory; women's care; dermatology; pain relief; GI More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
UK Marketing Partner
Are you a small to medium company seeking a UK presence? More
Acquisition of UK Hospital established brands
UK partner for strategic divestments More
Acquisition of UK Primary Care ethical brands
Strategic divestments of primary care sales focussed brands More
Injectables and oral medicines for hospital use
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Seeking to in-license late stage prescription products into the Nordic region
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries. More
Prescription bound chemical substances (NCEs) OR new value added prescription products to in-license for the Nordic market
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark. More
Novel, ready-to-market, next generation of pain relief patch product sought for topical analgesic leader
Our analgesic specialists are seeking a new, innovative and novel patch product for the treatment of pain to add to their portfolio. More
New, innovative CNS drug sought at end of Phase III trial level
New innovative drug to be used in some CNS-areas, primarily to support a product indicated for schizophrenia More
Displaying 1..10 of 10 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Apr 2010 - 510 pages - $2,695
Company Financials: Acadia Pharmaceuticals Inc.
Jan 2010 - $75
Is IMS billing simplifying billing?
Jan 2007 - 10 pages - $1,100
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010
Aug 2010 - 76 pages - $1,500
Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, Q4, 2010
Dec 2010 - 65 pages - $1,000
Company Financials: Alexza Pharmaceuticals
Jan 2010 - $75
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us